Although all of the patents have expired for Treanda (bendamustine), a generic version of this drug is not available at this time. This is because there are still exclusivity rights in place until September 2015, which is likely the earliest predictable date that a generic version might become available.
Can I Buy Generic Treanda?Treanda® (bendamustine) is a prescription cancer medication. It is approved to treat certain types of leukemia and non-Hodgkin's lymphoma.
Treanda is made by Cephalon, Inc. It is currently protected by exclusivity rights that prevent a generic version from being manufactured in the United States.
When Will a Generic Version Be Available?It is difficult to predict when a generic Treanda product will become available. The medication is no longer protected by patents; however, it is protected by exclusivity rights, which are similar to patents. Although one exclusivity right expired in October 2011, the others do not expire until September 2015. This is likely the earliest predictable date that a generic version could become available.
In addition, other circumstances could come up to extend or delay this exclusivity period. This could include such things as lawsuits or other patents for new Treanda uses.
Is Bendamustine a Generic Treanda?No -- bendamustine is the active ingredient in Treanda, not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.